Lynn E Heasley Selected Research

Lynn E Heasley Research Topics

Disease

35	Neoplasms (Cancer) 01/2022 - 09/2002
20	Lung Neoplasms (Lung Cancer) 05/2021 - 10/2002
14	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020 - 09/2006
10	Squamous Cell Carcinoma of Head and Neck 01/2022 - 08/2011
5	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2021 - 09/2002
3	Squamous Cell Neoplasms (Squamous Cell Cancer) 12/2019 - 10/2015
3	Carcinogenesis 03/2011 - 04/2006
2	Malignant Mesothelioma 01/2020 - 10/2014
2	Mesothelioma 01/2020 - 10/2014
2	Adenocarcinoma of Lung 01/2020 - 01/2018
2	Carcinoma (Carcinomatosis) 01/2018 - 10/2002
2	Leukemia 12/2015 - 04/2013
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 10/2013 - 04/2013
1	Breast Neoplasms (Breast Cancer) 01/2021
1	Liposarcoma 01/2021
1	Lewis Lung Carcinoma 01/2020
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2018
1	Inflammation (Inflammations) 01/2018
1	Pneumonia (Pneumonitis) 01/2018
1	Hepatitis 01/2018
1	Exanthema (Rash) 01/2018
1	Residual Neoplasm 01/2017
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2015
1	Triple Negative Breast Neoplasms 01/2015
1	Hypoxia (Hypoxemia) 09/2014
1	Adenocarcinoma 06/2014
1	Infections 10/2013
1	Neoplasm Metastasis (Metastasis) 10/2013
1	Pathologic Processes 01/2013

Drug/Important Bio-Agent (IBA)

12	Tyrosine Kinase InhibitorsIBA 05/2021 - 01/2009
10	Phosphotransferases (Kinase)IBA 12/2019 - 04/2006
9	Messenger RNA (mRNA)IBA 01/2019 - 08/2011
9	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 01/2019 - 01/2009
8	Proteins (Proteins, Gene)FDA Link 01/2018 - 05/2005
6	Biomarkers (Surrogate Marker)IBA 01/2021 - 10/2013
6	ErbB Receptors (EGF Receptor)IBA 01/2021 - 01/2009
6	ponatinibIBA 01/2019 - 06/2014
4	Pharmaceutical PreparationsIBA 01/2022 - 09/2014
4	Gefitinib (Iressa)FDA Link 01/2021 - 01/2009
4	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 12/2019 - 05/2005
4	LigandsIBA 01/2017 - 01/2009
3	Cetuximab (Erbitux)FDA Link 01/2021 - 01/2015
3	CrizotinibIBA 02/2018 - 03/2012
3	tyrosine receptor (receptor, tyrosine)IBA 01/2018 - 04/2013
3	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 07/2015 - 01/2009
3	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 07/2015 - 08/2011
3	PPAR gammaIBA 03/2008 - 11/2002
2	CarcinogensIBA 01/2022 - 03/2011
2	InterferonsIBA 05/2021 - 01/2021
2	Biological ProductsIBA 01/2021 - 01/2013
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2020 - 12/2019
2	AsbestosIBA 01/2020 - 10/2014
2	B7-H1 AntigenIBA 01/2020 - 01/2017
2	Protein Kinases (Protein Kinase)IBA 12/2019 - 10/2015
2	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 12/2019 - 08/2011
2	Mitogen-Activated Protein KinasesIBA 12/2019 - 09/2002
2	SilverIBA 01/2019 - 07/2015
2	AZD4547IBA 01/2018 - 10/2015
2	Cisplatin (Platino)FDA LinkGeneric 01/2017 - 09/2002
2	Small Interfering RNA (siRNA)IBA 01/2017 - 04/2013
2	Cadherins (E-Cadherin)IBA 01/2017 - 05/2005
2	Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)IBA 07/2015 - 10/2013
2	FP-1039IBA 10/2014 - 08/2011
2	Transcription Factors (Transcription Factor)IBA 09/2014 - 09/2002
2	JNK Mitogen-Activated Protein KinasesIBA 05/2010 - 09/2002
2	gamma Catenin (Plakoglobin)IBA 05/2004 - 10/2002
1	EphB4 ReceptorIBA 01/2022
1	osimertinibIBA 05/2021
1	AZD 8931IBA 01/2021
1	eribulin FDA Link 01/2021
1	liquid crystal polymerIBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2020
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2020
1	Interferon-gamma (Interferon, gamma)IBA 01/2020
1	Sirolimus (Rapamycin)FDA Link 12/2019
1	Anaplastic Lymphoma KinaseIBA 02/2018
1	CytokinesIBA 01/2018
1	ChemokinesIBA 01/2018
1	MicroRNAs (MicroRNA)IBA 01/2018
1	Interferon Type IIBA 01/2018
1	Immune Checkpoint InhibitorsIBA 01/2017
1	Vinorelbine (Navelbine)FDA LinkGeneric 01/2017
1	(5- (2,4- bis((3S)- 3- methylmorpholin- 4- yl)pyrido(2,3- d)pyrimidin- 7- yl)- 2- methoxyphenyl)methanolIBA 12/2015
1	MTOR InhibitorsIBA 10/2015
1	vistusertibIBA 10/2015
1	infigratinibIBA 10/2015
1	Transforming Growth Factor beta (TGF-beta)IBA 01/2015
1	Monoclonal AntibodiesIBA 01/2015
1	1-methyl-1-piperidinomethane sulfonateIBA 10/2014
1	Pyruvate Dehydrogenase Acetyl-Transferring KinaseIBA 09/2014
1	bosutinibIBA 09/2014
1	Formaldehyde (Formol)FDA Link 10/2013
1	Nicotine FDA Link 10/2013
1	ParaffinIBA 10/2013
1	Proto-Oncogene Proteins c-metIBA 04/2013
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2013

Therapy/Procedure

20	Therapeutics 01/2022 - 04/2006
4	Immunotherapy 01/2020 - 01/2017
2	Precision Medicine 01/2018 - 09/2014
1	Drug Therapy (Chemotherapy) 12/2019